Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03407378 · ClinicalTrials.gov registry record · Phase 1
A Study to Investigate a New Treatment in Patients With Parkinson's Disease
A Phase 1 study of Parkinson Disease, sponsored by Tools4Patient.
- Completed
- Registry status
- Phase 1
- Development phase
- 110
- Enrollment target
- 10
- Study locations
NCT03407378 is a Phase 1 study of Parkinson Disease that has completed, run by Tools4Patient. The registered enrollment target is 110 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The trial reports 10 study locations across 6 states.
The verdict
NCT03407378, a Phase 1 study of Parkinson Disease, has completed, sponsored by Tools4Patient.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 110 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of this clinical trial conducted in patients with Parkinson's Disease is to study the relationship between patient individual profile and their response to IPT803 Adjunct Treatment (treatment response being characterized by movements improvement).
Conditions Studied
Interventions
- OTHER Questionnaires
- DRUG IPT803
- GENETIC Optional pharmacogenetic assessment
- OTHER Optional Blood-Oxygen-level Dependent functionalMRI
- OTHER Motor Assessments before taking regular PD treatment
Study Locations (10)
Other
- CHU Liege - Liège University - Liège
- CHU Grenoble - Grenoble
- CHU Poitiers - Poitiers
- CHU Rennes - Hopital Pontchaillou - Rennes
- CHU Purpan - Hopital Pierre Paul Riquet - Toulouse
Colorado
- University of Colorado School of Medicine - Aurora
Florida
- University of Florida - Gainesville
Illinois
- Northwestern - Chicago
Michigan
- Henry Ford - West Bloomfield
New York
- Columbia - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2018-06-26 |
| Est. Completion | 2020-03-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03407378
The ClinicalTrials.gov registry entry for NCT03407378 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The listed sponsor is Tools4Patient, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 5 interventions - of which Questionnaires is the first listed.
NCT03407378 reports 10 study locations spanning 6 distinct geographic areas - top geographies include Other, Colorado, Florida.
Frequently Asked Questions
What is clinical trial NCT03407378 about?
NCT03407378 is a clinical study titled "A Study to Investigate a New Treatment in Patients With Parkinson's Disease". The purpose of this clinical trial conducted in patients with Parkinson's Disease is to study the relationship between patient individual profile and their response to IPT803 Adjunct Treatment (treatment response being characterized by movements improvement).
What is the current status of trial NCT03407378?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 110 participants. The study started on 2018-06-26. Estimated completion is 2020-03-31.
What conditions does trial NCT03407378 study?
This clinical trial studies the following conditions: Parkinson Disease.
What interventions are being tested in trial NCT03407378?
The interventions under investigation include: Questionnaires (OTHER), IPT803 (DRUG), Optional pharmacogenetic assessment (GENETIC), Optional Blood-Oxygen-level Dependent functionalMRI (OTHER), Motor Assessments before taking regular PD treatment (OTHER).
Who is sponsoring clinical trial NCT03407378?
This trial is sponsored by Tools4Patient, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03407378 being conducted?
This trial has 10 study locations across Colorado, Florida, Illinois, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
RECRUITING · Phase 1
-
Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons
RECRUITING · Phase 1
-
First-in-Human Single and Multiple Dose of HL-400
RECRUITING · Phase 1
-
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
RECRUITING · Phase 1
-
[18F]F-DOPA Imaging in Patients With Autonomic Failure
RECRUITING · Phase 1
-
A Study to Assess the Safety of BMS-984923 Compared to Placebo, in People With Parkinson's
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.